Tibofem
Tibofem

2.79
A generic medicine indicated for hormonal and menopause conditions. Replaces natural hormonal activity by binding to estrogen receptors to ease systemic fluctuations.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tibolone
Reference Brand
Tibolone
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones, Menopause & HRT, Hormone Therapy
Product Category
Synthetic Steroid
Pharmacological Class
Estrogen Receptor Agonist
Manufacturer Description
Designed to support estrogen receptor activation to manage menopausal hot flashes and alleviate bone loss.
Mechanism of Action
Metabolizes into compounds that exert tissue-specific estrogenic, progestogenic, and androgenic activity, normalizing endocrine function.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Pregnancy, History of breast cancer, Active thromboembolic disease
Severe Adverse Events
Stroke — requires immediate medical attention, Endometrial cancer — requires immediate medical attention
Common Side Effects
Vaginal discharge, Headache, Abdominal pain
Uncommon Side Effects
Breast pain, Weight change, Hirsutism
Drug Interactions
Warfarin, Anticonvulsants
Pregnancy Safety Warnings
TGA Category X: Highly contraindicated. Strictly avoid in pregnancy. Breastfeeding: Contraindicated.
Age Restrictions
Approved for postmenopausal adult females.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Tibofem is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Type 2 Diabetes Tablets - Januvia Australia